Precision VIR Announces Non-surgical Option for Patients with Varicose Veins

Vein expert doctors at Precision VIR in Dallas, TX announce Varithena as a non-surgical option for varicose vein patients. Sadly, vein disease does not cure itself and can get worse if untreated. Precision VIR can reduce varicose vein symptoms and improve leg appearance.

Dallas, United States - April 17, 2018 /PressCable/ —

Precision VIR Announces Availability of Varithena® as a Non-Surgical Option for Patients with Symptoms Related to or Caused by Varicose Veins

The Cutting-Edge Procedure can Reduce a Variety of Symptoms and Improve Vein Appearance

Dallas, TX (April 16, 2018) – The doctors at Precision Vascular & Interventional recently announced they incorporated Varithena® (polidocanol injectable foam) into the growing list of superior vein treatment options for their patients. Varithena is a non-surgical prescription medicine many believe can be a game-changer when it comes to treating varicose veins, specifically in combating the symptoms of heaviness, achiness, swelling, throbbing and itching.

“Precision VIR is delighted to provide patients with this non-surgical option,” Dr. Danny Chan said on behalf of himself, Dr. Jaryd Stein, and their associate vein specialists. “We have been specially trained in using Varithena. Treatment is minimally-invasive—which means no incision is required.”

Dr. Chan added, “The Varithena procedure usually takes less than one hour, and patients may resume light activities as quickly as the same day of treatment.”

More About Varicose Veins and Varithena

Varicose veins are enlarged bulging veins usually found above the surface of the skin on the legs and are a telltale sign of vein disease, where vein walls and valves have become weakened and eventually interrupt normal blood flow. These veins can range from the most common spider and varicose veins to skin breakdown and venous ulcers. More than 20 million Americans suffer from vein disease or venous disorders.

Sadly, vein disease does not cure itself and can get worse if left untreated. Luckily, there are a variety of treatment options available for patients with venous conditions, including Varithena, Sclerotherapy, ClosureFast, and Microphlebectomy.

Varithena (polidocanol injectable foam) is the latest option. It is administered through a catheter or by direct injection into the malfunctioning vein. The foam fills the desired section of the vein, and the diseased vein collapses. Blood flow then shifts to healthier veins nearby. This procedure does not require incisions. While the doctor usually numbs the injection site, no additional anesthesia is required.

Varithena treats a wide range of varicose veins in the GSV system, including:

• Tortuous (twisted) veins

• Veins above and below the knee

• Veins with small, medium, and large diameters

• Veins previously treated with other methods

Varithena® is a registered trademark of Provensis Ltd, a BTG International group company.

Precision VIR – Committed to Helping Patients Lead Normal Lives

Precision VIR has long been at the forefront of performing leading-edge procedures to treat vein disease such as varicose veins, spider veins, deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and peripheral arterial disease/peripheral vascular disease (PAD/PVD)—all while providing compassionate patient care.

With multiple locations in the Dallas-Fort Worth area, Precision VIR was established in 2012 as the first independent Vascular and Interventional Radiology practice in North Texas. They focus only on minimally-invasive procedures and surgeries that are the safest and most efficient options for patients. There are no large incisions, which allows for a reduction in risk, less pain, and shorter recovery time.

All physicians at Precision VIR are Board Certified Diagnostic Radiologists with additional Fellowship training in Vascular and Interventional Radiology. Precision VIR serves Dallas, Fort Worth, Carrollton, Richardson, Garland, Mesquite, Highland Park, University Park, Park Cities, Plano, Frisco, Allen, McKinney, Flower Mound, Lewisville, Denton, Arlington, Irving, Grand Prairie and all of North Texas. Precision VIR doctors are area leaders in vascular disease diagnosis and treatment for conditions such as varicose veins, spider veins, deep vein thrombosis (DVT), chronic venous insufficiency (CVI), peripheral arterial disease/peripheral vascular disease (PAD/PVD), IVC filters, women’s pelvic congestion syndrome, male varicoceles and female uterine fibroids.

For more information on Varithena, visit the Precision VIR FAQ page or to see if this procedure is the right treatment for your varicose veins, schedule a consultation by calling (214) 382-3200.

– end –

###

Contact Info:
Name: Shauna Robinson or Madison Horan
Email: info@precisionvir.com
Organization: Precision VIR
Address: 12400 Coit Road, Suite 505, Dallas, TX 75251, United States
Phone: +1-214-382-3200

For more information, please visit https://www.precisionvir.com/vein-care-dallas/

Source: PressCable

Release ID: 331770

More News From thebudgetreport.com

HRW: 'Men only' job ads show ongoing discrimination in China

Apr 23, 2018

BEIJING — One job ad for Chinese high-speed train conductors called for candidates who were "fashionable and beautiful." Another ad targeting men for a job in a Chinese internet company included photos of a female employee pole-dancing. Gender discrimination is widespread in the Chinese workforce, a human rights group said Monday, with many hiring advertisements openly calling only for male applicants and using the attractiveness of female co-workers as a draw. Human Rights Watch released its report, "Only Men Need Apply: Gender Discrimination in Job Advertisements in China" after looking at more than 36,000 job advertisements posted between 2013 and...

World shares mostly lower, tracking tech sell-off on Wall St

Apr 23, 2018

Global shares were mostly lower Monday following Friday's steep slide in technology shares on Wall Street. Markets had only a muted reaction, if any, to North Korea's announcement that it would stop nuclear and missile testing. KEEPING SCORE: Britain's FTSE 100 was almost unchanged at 7,365.29. Germany's DAX edged 0.1 percent lower to 12,522.34 and the CAC 40 of France declined 0.2 percent to 5,404.24. The future for the S&P 500 lost 0.1 percent and the future for the Dow lost 0.2 percent. ASIA'S DAY: Tokyo's Nikkei 225 fell 0.3 percent to 22,088.04 and South Korea's Kospi shed 0.1 percent...

Eurozone interest rates could stay frozen well into 2019

Apr 23, 2018

FRANKFURT, Germany — When will the European Central Bank join the U.S. Federal Reserve and start raising interest rates? This much is clear: It won't be soon. Weaker signals from the economy and worries about a possible trade war between the United State and China have left the top monetary authority for the 19 countries that use the euro in no hurry to start withdrawing its monetary stimulus. And that means the central bank's short-term interest rate benchmark will almost certainly stay at zero well into next year, ensuring low borrowing costs for businesses but miserly returns for savers. Analysts...

Asian shares mostly lower, tracking tech sell-off on Wall St

Apr 23, 2018

Shares were mostly lower in Asia on Monday following Friday's steep slide in technology shares on Wall Street. Markets had only a muted reaction, if any, to North Korea's announcement that it would stop nuclear and missile testing. KEEPING SCORE: Tokyo's Nikkei 225 fell 0.3 percent to 22,091.73 and South Korea's Kospi shed 0.2 percent to 2,471.25. Hong Kong's Hang Seng declined 0.4 percent to 30,288.71 and the Shanghai Composite index dropped 0.2 percent to 3,064.80. Australia's S&P ASX 200 advanced 0.4 percent to 5,889.30. Shares were higher in Singapore but fell in Indonesia and Thailand. WALL STREET: Losses in...

AP FACT CHECK: Trump distorts NKorea aim to 'denuclearize'

Apr 23, 2018

WASHINGTON — President Donald Trump and his aides are leaving a false impression about the extent of North Korea's plans to give up its nuclear weapons. They say North Korean dictator Kim Jong Un has basically agreed to "denuclearization." In fact, Kim's announcement Friday before summits with the U.S. and South Korea is more limited, agreeing to freeze missile and nuclear weapons tests and close one nuclear facility already believed to have been rendered unusable. There is no mention by North Korea of full nuclear disarmament. Meanwhile, Trump offered a shifting rationale in recent days for his firing of FBI...

The Budget Report seeks to provide comprehensive coverage and analysis on the current economic, financial issues around the world. First hand finance and economic news all day, every day.

Contact us: sales@thebudgetreport.com